Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Gastrointestinal Stromal Tumors × Dalteparin × Clear all

Sponsor

Conditions

Venous Thromboembolism 7 Pulmonary Embolism 5 Venous Thrombosis 4 Neoplasms 4 Neoplasm Metastasis 2 Thrombosis 1 Sarcoma 1 Pancreatic Neoplasms 1 Multiple Myeloma 1 Mesenteric Ischemia 1 Lymphoma 1 Intracranial Thrombosis 1 Fractures, Spontaneous 1 Femoral Fractures 1 Bone Neoplasms 1 Acute Deep Vein Thrombosis 1

Interventions

Sunitinib 14 Imatinib Mesylate 12 nilotinib 7 ripretinib 3 regorafenib 3 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 3 pexidartinib 2 pembrolizumab 2 avapritinib 2 Bevacizumab 2 trametinib 1 spartalizumab 1 romidepsin 1 ponatinib 1 pazopanib 1 palbociclib 1 olaratumab 1 guadecitabine 1 ferric carboxymaltose 1 epacadostat 1 dabrafenib 1 cediranib 1 Surveys and Questionnaires 1 Sorafenib 1 Observation 1 Iron-Dextran Complex 1 Indocyanine Green 1 Immunoglobulin G 1 HhAntag691 1 Fluorescein 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡